SCHX vs VOOG: 62% overlap
Schwab U.S. Large-Cap ETF and Vanguard S&P 500 Growth ETF share 62.1% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published 30 days apart — SCHX as of 2026-05-31, the rest through 2026-06-30. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.4. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
SCHX and VOOG hold 134 of the same securities. The ten contributing most to the overlap figure:
| Holding | in SCHX | in VOOG | Δ |
|---|---|---|---|
| NVDA | 7.5% | 13.7% | 6.2% |
| AAPL | 6.7% | 6.0% | 0.7% |
| MSFT | 4.9% | 7.8% | 2.9% |
| AMZN | 3.9% | 3.5% | 0.4% |
| GOOGL | 3.2% | 5.9% | 2.7% |
| AVGO | 3.1% | 5.0% | 1.9% |
| GOOG | 2.6% | 4.7% | 2.1% |
| META | 2.0% | 3.5% | 1.5% |
| TSLA | 1.8% | 2.1% | 0.3% |
| MU | 1.6% | 3.7% | 2.1% |
Where SCHX and VOOG differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | SCHX | VOOG | Δ |
|---|---|---|---|
| Information Technology | 36.8% | 52.2% | −15.5pp |
| Communication Services | 10.1% | 15.2% | −5.1pp |
| Unclassified | 3.4% | 0.0% | +3.4pp |
| Consumer Staples | 4.4% | 1.1% | +3.3pp |
| Energy | 3.2% | 0.0% | +3.2pp |
| Financials | 10.9% | 8.5% | +2.4pp |
| Health Care | 8.1% | 6.2% | +2.0pp |
| Utilities | 2.0% | 0.4% | +1.7pp |
Δ is SCHX minus VOOG, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
36.2% of SCHX by weight, held in no part of VOOG.
2.6% of VOOG by weight, held in no part of SCHX.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| SCHX | VOOG | |
|---|---|---|
| Top 10 holdings | 37.3% | 56.4% |
| Positions held | 750 | 148 |
| Cost per $10,000 held, per year | $3 | $7 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do SCHX and VOOG overlap?
SCHX and VOOG overlap 62.1% by portfolio weight — substantial duplication if you hold both. They share 134 holdings. The figure comes from current issuer holdings files (SCHX as of 2026-05-31, VOOG as of 2026-06-30).
How is the overlap between SCHX and VOOG calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If SCHX holds a stock at 6% and VOOG holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both SCHX and VOOG?
That depends on your goals — we state facts, not advice. At 62.1% overlap, each fund still contributes meaningfully distinct exposure.
What does SCHX own that VOOG doesn't?
SCHX holds 750 positions and VOOG holds 148; 615 of SCHX's positions don't appear in VOOG at all, and they are 36.2% of SCHX by weight.
You probably hold more than two funds
This page compares SCHX and VOOG. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch SCHX vs VOOG
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, SCHX as of 2026-05-31, VOOG as of 2026-06-30. Weights are fractions of each fund. Diagnostics, not advice.